Poiesis Medical, a company focused on delivering advanced urinary products targeting patient-centric outcomes, offers the Duette dual balloon catheter. Designed to reduce Catheter-Related Bladder Discomfort (CRBD) and Catheter-Associated Urinary Tract Infections (CAUTIs).
“It is established that the Foley catheter is the causative agent in over 13,000 deaths annually,” says Gregory D. Wiita Founder and CEO. “We have produced the first change to this widely used catheter. We are happy to state that clinical results in controlled and real-world studies (RWS) confirm the benefits of Dual balloon (Duette) catheter technology compared to single balloon (Foley) devices.”
One hundred million indwelling urinary catheters (Foleys) are employed worldwide annually. A review of common complications caused by this 85-year-old design has resulted in the first change to this widely utilized medical device.
A large percentage of patients with indwelling urinary catheters are likely to get bacterial infections, bladder spasms, leakage, bladder stones, and hematuria research has demonstrated bacteria alone are NOT the reason for many of these catheter-related infections. It is time for catheter innovations, seeing the need for new and innovative design, Poiesis Medical researched and developed the Duette dual balloon catheter.
In conventional catheters, as the bladder drains, it collapses around the tip, causing the tip to become embedded in the bladder lining. The direct contact of the bladder’s glycosaminoglycan (GAG) protective layer can be damaged by contact. This can result in bladder spasms that disturb the position of the anchor balloon. The dreaded combination of trauma and the presence of bacteria increases the risk of bacterial attachment and its proliferation.
Duette has an innovative design. It is the first new design change to catheters. The zero-tip dual balloon catheter prevents trauma to the mucosal lining of the catheter. Duette’s cushioning balloon protects the surface mucin’s antibacterial mechanisms and the integrity of the cells below. With issued patents around the world, Poiesis is proud to own the space around and attached to the tip of the catheter. The Dual Balloon technology Duette can be deployed across the many different care areas where catheters are utilized. The challenge for innovators is to offer a design that accomplishes important medical improvements but also provides the end user flexibility.
Healthcare systems are moving to standardize the number of products and vendors. Employing the Dual Balloon technology is convenient the Duette device comes in four (4) French sizes, three (3) temperature sensing sizes, and closed procedural kits with three (3) sizes in acute setting/post-acute styles that follow Joint Commission guidelines.
The drainage eyes of Duette are located between the two balloons to prevent further damage from aspiration of the mucosal lining. This design also ensures complete drainage due to the protected catheter eyes. Of note the design function whether the user is mobile or in a horizontal position. It can be easily inserted and removed and requires little new training of personnel. The brand also maintains cost parity with the present silicone catheter models. The Dual Balloon Duette is supported by reimbursement codes both Healthcare Finance Administration Common Procedural Coding System (HCPC) and ICD-10.
According to Gregory D. Wiita Founder and CEO, the current Foley catheter attacks the body’s natural defenses, which results in serious complications, including urosepsis and even bladder cancer. “Just as skin protects against bacteria entering the body, the bladder protection system (the mucosal lining) helps keep bacteria from colonizing the bladder wall.” In the US alone costs due to complications caused by indwelling catheters run over $25 billion annually. The introduction of an advanced and effective catheter can alleviate these infections. Duette can help medical professionals provide much-needed relief from catheter complications, increasing patients’ quality of life (QoL).
For more information, visit https://www.poiesismedical.com/.
An update to be released by Poiesis Medical to include recent clinical outcomes data from leading medical institution and clinical outcomes data from a leading medical institution (Mayo Clinic) will be presented. Additionally, the company will present outcomes data from all current medical segments where indwelling catheters are utilized. Finally, management will express the importance for all medical device companies to perform safety and efficacy studies before venturing into human trials. The Duette was cleared through the Food and Drug Administration (FDA) is on the market today and has sold over 400,000 Duette products to date. No other company in this space can claim a similar safety profile and real-world market experience.
About Poiesis Medical
Poiesis Medical LLC was founded by Dr. Bruce E. Wiita and his son, Gregory D. Wiita, a pair of experienced entrepreneurs with a demonstrated ability to develop market-leading positions in the medical device field. As industry veterans, they bring a wealth of experience and a brilliant track record to a new and innovative company. Poiesis Medical is committed to delivering advanced urinary products for better patient care. Poiesis Medical is poised to provide innovative solutions to the world’s healthcare systems. Product is currently represented in US, New Zealand, Australia, Canada, China, Middle East, Africa, Brazil.
Company Name: Poiesis Medical
Contact Person: Charlene Johnson
Email: Send Email
Address:151 Fern Street Suite 1
Country: United States